U-Blot® Research Grade RinucumabCat. No. WA3460Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade RinucumabCat. No. WA3460
U-Blot® Research Grade RinatabartCat. No. WA3459
U-Blot® Research Grade RimteravimabCat. No. WA3458
U-Blot® Research Grade RilvegostomigCat. No. WA3457
U-Blot® Research Grade RiltovetbartCat. No. WA3456
U-Blot® Research Grade RilotumumabCat. No. WA3455
U-Blot® Research Grade RilonaceptCat. No. WA3454
U-Blot® Research Grade rilogrotugCat. No. WA3453
U-Blot® Research Grade RiliprubartCat. No. WA3452
U-Blot® Research Grade ricefidaseCat. No. WA3451
U-Blot® Research Grade RezorstobartCat. No. WA3450
U-Blot® Research Grade RezetamigCat. No. WA3449